September 08, 2013
Study Published in Nature Biotechnology Demonstrates Ability of Moderna’s Novel Therapeutic Paradigm to Repair and Regenerate Damaged Heart Tissue
July 31, 2013
Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development
May 22, 2013
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
April 30, 2013
Henri A. Termeer Joins Moderna Therapeutics Board of Directors
March 21, 2013
AstraZeneca and Moderna Therapeutics Announce Exclusive Agreement to Develop Pioneering Messenger RNA Therapeutics™ in Cardiometabolic Diseases and Cancer
February 27, 2013
Massachusetts Life Sciences Center Awards Tax Incentives to 25 Companies (PDF File)
January 13, 2013
Moderna Appoints Divakar Ramamakishnan, Ph.D., as Senior Vice President of Process Development, Manufacturing and Quality
December 19, 2012
Moderna Appoints Stephen Hoge as Senior Vice President of Corporate Development and New Drug Concepts
December 06, 2012
Moderna Announces $40 Million In Financing To Advance Development Of New Biotherapeutic Modality: Messenger RNA Therapeutics™
February 22, 2012
Massachusetts Life Sciences Center Announces Tax Incentives Targeting Growth at 28 Companies (PDF File)